1-3 of 3
Wim J Tissing, MD PhD
Close
Sort by
Journal Articles

Toxicity of Very Prolonged Pegasparaginase and Erwinia Asparaginase Courses in Relation to Asparaginase Activity Levels with a Special Focus on Dyslipidemia

Wing H. Tong, MD PhD, Rob Pieters, Hester A. de Groot-Kruseman, PhD, Wim C.J. Hop, PhD, Joachim Boos, MD PhD, Wim J Tissing, MD PhD, Inge M. van der Sluis, MD PhD
Journal: Blood
Blood (2014) 124 (21): 2256.
https://doi.org/10.1182/blood.V124.21.2256.2256
Published: 2014
Journal Articles

Should We Use a Desensitization Protocol In Acute Lymphoblastic Leukemia Patients With Silent Inactivation Of Pegasparaginase?

Wing H. Tong, MD, Rob Pieters, Wim J Tissing, MD, PhD, Inge M. van der Sluis, MD, PhD
Journal: Blood
Blood (2013) 122 (21): 1434.
https://doi.org/10.1182/blood.V122.21.1434.1434
Published: 2013
Journal Articles

A Prospective Study On Drug Monitoring Of Pegasparaginase and Erwinia Asparaginase and Asparaginase Antibodies In Pediatric Acute Lymphoblastic Leukemia

Wing H. Tong, MD, Rob Pieters, Gertjan Kaspers, MD, PhD, Maroeska D.W.M. te Loo, MD, PhD, Marc Bierings, Cor van den Bos, MD, PhD, Wouter J.W. Kollen, MD, PhD, Wim C.J. Hop, PhD, Joachim Boos, MD, PhD, Mary V. Relling, PharmD, Hans Juergen Kuehnel, MD, Wim J Tissing, MD, PhD, Inge M. van der Sluis, MD, PhD
Journal: Blood
Blood (2013) 122 (21): 2634.
https://doi.org/10.1182/blood.V122.21.2634.2634
Published: 2013